Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic
Introduction: Psychotropic drug-drug interactions (DDIs) contribute to adverse drug events, but many go undetected or unmanaged. Thorough documentation of potential DDIs can improve patient safety. The primary objective of this study is to determine the quality of and factors associated with documen...
Na minha lista:
Principais autores: | Kathryn Collins, PharmD, MSPH (Autor), Julie A. Dopheide, PharmD, BCPP, FASHP (Autor), Mengxi Wang, MPH (Autor), Talene Keshishian, MD (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
American Association of Psychiatric Pharmacists,
2023-03-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Positioning psychiatric pharmacists to improve mental health care
por: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Publicado em: (2022) -
Terbinafine and risperidone drug interaction contributing to clinical changes in a forensic psychiatric patient
por: Reynolds Jamie PharmD, et al.
Publicado em: (2023) -
A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
por: Jonathan F. Lister, PharmD, BCPP, et al.
Publicado em: (2022) -
Psychotropic stewardship: Advancing patient care
por: Haight Robert J. PharmD, BCPP, et al.
Publicado em: (2023) -
Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
por: Richard J. Silvia, PharmD, BCPP, et al.
Publicado em: (2022)